Geneva, Switzerland, January 9, 2020 – 5:50pm CET – GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases will participate to the LifeSci Advisors Corporate Access Event from January 13 to 16, 2020, in San Francisco, USA, concurrent with the J.P. Morgan Healthcare conference.
https://geneuro.ch/data/news/2020.01.09-GeNeuro-PR-investor-meetings-eng.pdf